Logo image
Se connecter
Treatment of refractory adult onset Still’s disease with combination anakinra and baricitinib therapy
Article de revue

Treatment of refractory adult onset Still’s disease with combination anakinra and baricitinib therapy

Chayma Ladhari, Christian Jorgensen et Yves-Marie Pers
Rheumatology, Vol.58(4), pp.736-737
01/04/2019
PMID: 30590753

Résumé

Adult onset Still’s disease (AOSD) is a rare, multisystemic inflammatory disorder of unknown aetiology. AOSD is a diagnosis of exclusion that needs to rule out infections, autoimmune or malignant diseases. Conventional therapies include non-steroidal anti-inflammatory drugs, corticosteroids, immunosuppressive drugs and biologics targeting in particular IL-1 or IL-6 [...].

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image